Olga Vasiljeva

Olga Vasiljeva

Executive Director, Head Of Platform Biology @ CytomX Therapeutics

About Olga Vasiljeva

Olga Vasiljeva serves as the Executive Director and Head of Platform Biology at CytomX Therapeutics, where she has worked since 2011. With a Ph.D. in Medical Sciences and extensive experience in oncology research and preclinical drug development, she has held significant positions at various esteemed institutions, including the Jozef Stefan Institute and the University of Freiburg.

Work at CytomX Therapeutics

Olga Vasiljeva serves as the Executive Director and Head of Platform Biology at CytomX Therapeutics. She has held this position since 2011, contributing to the company's focus on developing innovative therapies in oncology. Her role involves overseeing platform biology initiatives, which are crucial for advancing the company's drug development pipeline. Under her leadership, CytomX Therapeutics has aimed to enhance the efficacy and safety of cancer treatments.

Education and Expertise

Olga Vasiljeva obtained her Ph.D. in Medical Sciences from the Jozef Stefan Institute and Siberian State Medical University, where she studied Physiology, Biochemistry, and Protease Biology from 1999 to 2003. She furthered her education as a Postdoctoral Fellow in Molecular Medicine at the Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University, from 2004 to 2006. Her academic background provides a strong foundation for her extensive experience in preclinical drug development and translational science, particularly in oncology.

Background

Prior to her current role, Olga Vasiljeva worked at the Jozef Stefan Institute as a Principal Investigator from 1999 to 2011. During this time, she conducted significant research in Ljubljana, Slovenia. She also served as a Postdoctoral Scientist at the University of Freiburg from 2004 to 2006, where she focused on molecular oncology and protease biology. This diverse background has equipped her with a comprehensive understanding of cancer research and drug development.

Achievements

Olga Vasiljeva has made substantial contributions to the field of oncology through her research and leadership roles. Her expertise in protease biology has been instrumental in advancing scientific knowledge and therapeutic strategies in cancer treatment. She has been recognized for her innovative leadership, emphasizing creativity and a scientific approach in her work, which has influenced the direction of research initiatives at CytomX Therapeutics.

People similar to Olga Vasiljeva